Press Release – New York, NY –March 1, 2024 – Sichenzia Ross Ference Carmel LLP represented ThinkEquity LLC and Laidlaw & Company (UK) Ltd. in an underwritten public offering of Oragenics Inc. …
Sichenzia Ross Ference Carmel LLP Represents EF Hutton LLC in $1.5 Million Underwritten Public Offering of NRx Pharmaceuticals
Press Release – New York, NY –February 28, 2024 – Sichenzia Ross Ference Carmel LLP represents EF Hutton LLC in $1.5 million underwritten public offering of NRx Pharmaceuticals (the “Company”) …
Sichenzia Ross Ference Carmel LLP Represented Vocodia Holdings Corp. In $5.95 Million Initial Public Offering on the BZX Exchange of CBOE Global Markets
Press Release – New York, NY – February 22, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Vocodia Holdings Corp. (the “Company”), an AI software company, in a $5.95 …
Sichenzia Ross Ference Carmel LLP Represents ThinkEquity LLC in $7.75 Million Initial Public Offering of Common Stock of Cel-Sci Corp.
Press Release – New York, NY – February 21, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented ThinkEquity LLC in the initial public offering of the common stock of Cel-Sci …
Sichenzia Ross Ference Carmel LLP Represents Lexaria Bioscience Corp. in a $3.6 Million Registered Direct Offering
Press Release – New York, NY – February 16, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Lexaria Bioscience Corp. (the “Company”), (NASDAQ: LEXX), a global innovator in …
Sichenzia Ross Ference Carmel LLP Represents Sunshine Biopharma, Inc. in $10.0 Million Underwritten Public Offering of Common Stock
Press Release – New York, NY – February 15, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Sunshine Biopharma, Inc. (NASDAQ: SBFM), a pharmaceutical company offering and …
